Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei (2022)
Lopes, Andre; Mello, Evandro Sobroza de; Lopez, Rossana Veronica Mendoza; Leonardi, Paulo Cesar; Ribeiro Junior, Ulysses 
Fonte: Journal of surgical research. Unidade: FM
Assuntos: NEOPLASIAS PERITONEAIS, PROGNÓSTICO, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Andre et al. Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei. Journal of surgical research, v. 274, p. 68-76, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jss.2022.01.001. Acesso em: 02 nov. 2025.APA
Lopes, A., Mello, E. S. de, Lopez, R. V. M., Leonardi, P. C., & Ribeiro Junior, U. (2022). Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei. Journal of surgical research, 274, 68-76. doi:10.1016/j.jss.2022.01.001NLM
Lopes A, Mello ES de, Lopez RVM, Leonardi PC, Ribeiro Junior U. Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei [Internet]. Journal of surgical research. 2022 ; 274 68-76.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.jss.2022.01.001Vancouver
Lopes A, Mello ES de, Lopez RVM, Leonardi PC, Ribeiro Junior U. Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei [Internet]. Journal of surgical research. 2022 ; 274 68-76.[citado 2025 nov. 02 ] Available from: https://doi.org/10.1016/j.jss.2022.01.001
